| scholarly article | Q13442814 |
| P50 | author | Manasi Shah | Q99544125 |
| Philipp E. Scherer | Q60572448 | ||
| Ilja L Kruglikov | Q89677053 | ||
| P2860 | cites work | Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1 | Q24298291 |
| Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6 | Q24616666 | ||
| Human nutrition, the gut microbiome and the immune system | Q24620449 | ||
| The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspective | Q26765407 | ||
| Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk | Q27023488 | ||
| A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury | Q28260798 | ||
| Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation | Q28389532 | ||
| Is adipose tissue a place for Mycobacterium tuberculosis persistence? | Q28469097 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study | Q30384494 | ||
| A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). | Q30398268 | ||
| Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study | Q30405999 | ||
| Obesity and the risk and outcome of infection | Q30416191 | ||
| Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. | Q33521906 | ||
| The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections | Q93256597 | ||
| Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | Q94478168 | ||
| Obesity could shift severe COVID-19 disease to younger ages | Q94538338 | ||
| Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis | Q94680716 | ||
| Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication | Q94685427 | ||
| Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China | Q94685447 | ||
| COVID-19 in diabetic patients: related risks and specifics of management | Q94938940 | ||
| Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits | Q95272307 | ||
| The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system | Q95645944 | ||
| Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study | Q95659103 | ||
| ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust | Q96109911 | ||
| Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza | Q96122174 | ||
| Relationship between COVID-19 and obesity | Q96160937 | ||
| Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank | Q96579884 | ||
| Thrombosis and COVID-19 pneumonia: the clot thickens! | Q96590044 | ||
| COVID-19 revisiting inflammatory pathways of arthritis | Q96610156 | ||
| The Lung Tissue Microbiota Features of 20 Deceased Patients with COVID-19 | Q96649399 | ||
| In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 | Q96768496 | ||
| Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study | Q97546781 | ||
| Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19 | Q97567103 | ||
| SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes | Q97567111 | ||
| COVID-19 in people with diabetes: understanding the reasons for worse outcomes | Q97597390 | ||
| Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity | Q97643685 | ||
| Managing Hyperglycemia in the COVID-19 Inflammatory Storm | Q98302547 | ||
| Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients | Q98657383 | ||
| Coronavirus (COVID-19) Pandemic and Health Workers of an Ethnic Group-A Slant on a Shocking Report | Q98663307 | ||
| Effect of porcine respiratory coronavirus infection on lipopolysaccharide recognition proteins and haptoglobin levels in the lungs | Q49084254 | ||
| Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia. | Q50218199 | ||
| Effect of diabetes mellitus on endotoxin-induced lung injury. | Q50515229 | ||
| Short-Term Versus Long-Term Effects of Adipocyte Toll-Like Receptor 4 Activation on Insulin Resistance in Male Mice. | Q50785259 | ||
| Increased levels of acute-phase serum proteins in diabetes. | Q51618740 | ||
| ADAM17-Mediated Ectodomain Shedding of Toll-Like Receptor 4 as a Negative Feedback Regulation in Lipopolysaccharide-Activated Aortic Endothelial Cells. | Q51743843 | ||
| Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. | Q52609376 | ||
| Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor. | Q55360608 | ||
| Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease. | Q55506426 | ||
| Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. | Q55641730 | ||
| Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus | Q59127020 | ||
| The endotoxin-induced pulmonary inflammatory response is enhanced during the acute phase of influenza infection | Q59357539 | ||
| Toll-like receptor 4 in acute viral infection: Too much of a good thing | Q60945182 | ||
| Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease | Q61875242 | ||
| Reactivation of antigen-induced arthritis in mice by oral administration of lipopolysaccharide | Q81063980 | ||
| Role of gut microbiota in type 2 diabetes pathophysiology | Q92416693 | ||
| High Fructose Intake and Adipogenesis | Q92635321 | ||
| Critical Role of Matrix Metalloproteinase 14 in Adipose Tissue Remodeling during Obesity | Q92976697 | ||
| Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area | Q93147595 | ||
| The pivotal link between ACE2 deficiency and SARS-CoV-2 infection | Q93237239 | ||
| Persistence of Coxiella burnetii, the agent of Q fever, in murine adipose tissue | Q33623657 | ||
| Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance | Q33840644 | ||
| Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice | Q34178121 | ||
| Elevated muscle TLR4 expression and metabolic endotoxemia in human aging | Q35029353 | ||
| CD14 modulates inflammation-driven insulin resistance | Q35123567 | ||
| Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. | Q35167982 | ||
| ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy | Q35760437 | ||
| The Gut-Lung Axis in Respiratory Disease | Q35848701 | ||
| Emerging pathogenic links between microbiota and the gut-lung axis. | Q36150861 | ||
| ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity | Q36392875 | ||
| Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry | Q36693984 | ||
| Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia | Q36827804 | ||
| ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. | Q36877738 | ||
| Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis | Q37101896 | ||
| Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies | Q37172453 | ||
| Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia | Q37418778 | ||
| Diabetes, insulin, and development of acute lung injury | Q37521491 | ||
| Initial viral load and the outcomes of SARS. | Q37610938 | ||
| Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse | Q37729150 | ||
| Polymicrobial respiratory disease in pigs | Q37966069 | ||
| Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens | Q38025737 | ||
| Review: Viral infections and mechanisms of thrombosis and bleeding | Q38038832 | ||
| Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling | Q38193206 | ||
| Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? | Q38221515 | ||
| Relation Between Obesity and Survival in Patients Hospitalized for Pulmonary Arterial Hypertension (from a Nationwide Inpatient Sample Database 2003 to 2011). | Q38732550 | ||
| Pathogenic mechanisms of intracellular bacteria | Q38992307 | ||
| Importance of cholesterol for infection of cells by transmissible gastroenteritis virus | Q39947080 | ||
| Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). | Q40404194 | ||
| Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide | Q41847844 | ||
| High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells | Q41849322 | ||
| Leptin resistance protects mice from hyperoxia-induced acute lung injury | Q42738508 | ||
| High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. | Q43117155 | ||
| Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus | Q45404876 | ||
| Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population | Q46160524 | ||
| Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway | Q46207876 | ||
| Haptoglobin and the inflammatory and oxidative status in experimental diabetic rats: antioxidant role of haptoglobin | Q46379099 | ||
| Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients | Q48233021 | ||
| A potential role for tumour necrosis factor-alpha in synergy between porcine respiratory coronavirus and bacterial lipopolysaccharide in the induction of respiratory disease in pigs | Q49075141 | ||
| Structural basis for human coronavirus attachment to sialic acid receptors | Q84315449 | ||
| Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide | Q84316079 | ||
| Virus interactions with bacteria: Partners in the infectious dance | Q89655622 | ||
| It's the fiber, not the fat: significant effects of dietary challenge on the gut microbiome | Q89662478 | ||
| Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury | Q89670059 | ||
| Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications | Q89761305 | ||
| SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients | Q89779929 | ||
| Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection | Q90255332 | ||
| Survival Benefit of Obese Patients With Pulmonary Embolism | Q90488625 | ||
| Viral dynamics in mild and severe cases of COVID-19 | Q90564410 | ||
| Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency | Q90698406 | ||
| COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus | Q90758519 | ||
| Diabetes is a risk factor for the progression and prognosis of COVID-19 | Q90788181 | ||
| Aging progression of human gut microbiota | Q90983597 | ||
| Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | Q91586974 | ||
| Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System | Q91703665 | ||
| ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway | Q91723901 | ||
| Incidence of thrombotic complications in critically ill ICU patients with COVID-19 | Q91931008 | ||
| ADAM17 inhibition may exert a protective effect on COVID-19 | Q91934668 | ||
| Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications | Q91956201 | ||
| Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes | Q92128732 | ||
| LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling | Q92257857 | ||
| P921 | main subject | comorbidity | Q1414874 |
| COVID-19 | Q84263196 | ||
| P577 | publication date | 2020-09-15 | |
| P1433 | published in | eLife | Q2000008 |
| P1476 | title | Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions | |
| P478 | volume | 9 |
| Q101214896 | miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19 | cites work | P2860 |
Search more.